Genetic and pharmacological evidence for a novel, intermediate phase of long-term potentiation suppressed by calcineurin
- PMID: 9489697
- DOI: 10.1016/s0092-8674(00)80896-x
Genetic and pharmacological evidence for a novel, intermediate phase of long-term potentiation suppressed by calcineurin
Abstract
To investigate the role of phosphatases in synaptic plasticity using genetic approaches, we generated transgenic mice that overexpress a truncated form of calcineurin under the control of the CaMKIIalpha promoter. Mice expressing this transgene show increased calcium-dependent phosphatase activity in the hippocampus. Physiological studies of these mice and parallel pharmacological experiments in wild-type mice reveal a novel, intermediate phase of LTP (I-LTP) in the CA1 region of the hippocampus. This intermediate phase differs from E-LTP by requiring multiple trains for induction and in being dependent on PKA. It differs from L-LTP in not requiring new protein synthesis. These data suggest that calcineurin acts as an inhibitory constraint on I-LTP that is relieved by PKA. This inhibitory constraint acts as a gate to regulate the synaptic induction of L-LTP.
Similar articles
-
Differential maintenance and frequency-dependent tuning of LTP at hippocampal synapses of specific strains of inbred mice.J Neurophysiol. 2000 Nov;84(5):2484-93. doi: 10.1152/jn.2000.84.5.2484. J Neurophysiol. 2000. PMID: 11067991
-
If phosphatases go up, memory goes down.Cell Mol Life Sci. 1999 Apr;55(4):549-53. doi: 10.1007/s000180050313. Cell Mol Life Sci. 1999. PMID: 10357225 Free PMC article. Review.
-
Enhanced synaptic transmission and reduced threshold for LTP induction in fyn-transgenic mice.Eur J Neurosci. 1999 Jan;11(1):75-82. doi: 10.1046/j.1460-9568.1999.00407.x. Eur J Neurosci. 1999. PMID: 9987012
-
Synaptic plasticity: going through phases with LTP.Curr Biol. 1998 May 7;8(10):R350-2. doi: 10.1016/s0960-9822(98)70219-2. Curr Biol. 1998. PMID: 9601635 Review.
-
Restricted and regulated overexpression reveals calcineurin as a key component in the transition from short-term to long-term memory.Cell. 1998 Jan 9;92(1):39-49. doi: 10.1016/s0092-8674(00)80897-1. Cell. 1998. PMID: 9489698
Cited by
-
Development of a monoclonal antibody specific for a calpain-generated ∆48 kDa calcineurin fragment, a marker of distressed astrocytes.J Neurosci Methods. 2024 Feb;402:110012. doi: 10.1016/j.jneumeth.2023.110012. Epub 2023 Nov 19. J Neurosci Methods. 2024. PMID: 37984591 Free PMC article.
-
Is It Time to Repurpose Calcineurin Inhibitors for the Treatment of Cognitive Impairment and Dementia?J Alzheimers Dis. 2023;95(2):599-602. doi: 10.3233/JAD-230780. J Alzheimers Dis. 2023. PMID: 37661889 Free PMC article.
-
Elevating the Levels of Calcium Ions Exacerbate Alzheimer's Disease via Inducing the Production and Aggregation of β-Amyloid Protein and Phosphorylated Tau.Int J Mol Sci. 2021 May 31;22(11):5900. doi: 10.3390/ijms22115900. Int J Mol Sci. 2021. PMID: 34072743 Free PMC article. Review.
-
Sleep Deprivation and Neurological Disorders.Biomed Res Int. 2020 Nov 23;2020:5764017. doi: 10.1155/2020/5764017. eCollection 2020. Biomed Res Int. 2020. PMID: 33381558 Free PMC article. Review.
-
Mechanism underlying hippocampal long-term potentiation and depression based on competition between endocytosis and exocytosis of AMPA receptors.Sci Rep. 2020 Sep 7;10(1):14711. doi: 10.1038/s41598-020-71528-3. Sci Rep. 2020. PMID: 32895399 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
